Prognostic and predictive value of estrogen receptor 1 expression in completely resected non-small cell lung cancer
Author:
Affiliation:
1. Krankenhaus Nordwest; University Cancer Center; Frankfurt am Main; Germany
2. STRATIFYER Molecular Pathology GmbH; Cologne; Germany
Publisher
Wiley
Subject
Cancer Research,Oncology
Reference41 articles.
1. Cancer survival and incidence from the Surveillance, Epidemiology, and End Results (SEER) program;Gloeckler Ries;Oncologist,2003
2. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group;Pignon;J Clin Oncol,2008
3. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer;Arriagada;N Engl J Med,2004
4. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial;Douillard;Lancet Oncol,2006
5. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer;Winton;N Engl J Med,2005
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Deciphering the potential therapeutic targets and mechanisms of jaranol for the treatment of COVID-19 and lung adenocarcinoma;Arabian Journal of Chemistry;2024-03
2. Molecular In Vitro and In Vivo Diagnostics as the Impartible Basis of Multimodal Therapy Approaches in Precision Oncology;Beyond Becquerel and Biology to Precision Radiomolecular Oncology: Festschrift in Honor of Richard P. Baum;2024
3. ERα-dependent estrogen-TNFα signaling crosstalk increases cisplatin tolerance and migration of lung adenocarcinoma cells;Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms;2021-08
4. Exposure to PM2.5 Enhances the PI3K/AKT Signaling and Malignancy of ERα Expression-dependent Non-small Cell Lung Carcinoma;BIOMED ENVIRON SCI;2021
5. Exploring the mechanism of aidi injection for lung cancer by network pharmacology approach and molecular docking validation;Bioscience Reports;2021-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3